Comorbidity in Small Cell Lung Cancer: Prognostic Impacts of Hypertension/Coronary Artery Disease, Diabetes Mellitus, and Chronic Obstructive Pulmonary Disease

References

• Hypertension - World Health Organization (WHO). 25 August 2021. https://www.who.int/news-room/fact-sheets/detail/hypertension.
   Google Scholar
• Cardiovascular diseases (CVDs) - World Health Organization (WHO). 11 June 2021. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds.).
   Google Scholar
• Diabetes - World Health Organization (WHO). 16 September, 2022. https://www.who.int/news-room/fact-sheets/detail/diabetes.
   Google Scholar
• Chronic obstructive pulmonary disease (COPD) - World Health Organization (WHO). 20 May 2022. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
   Google Scholar
• Aarts MJ, Aerts JG, van den Borne BE, Biesma B, Lemmens VEPP, Kloover JS. Comorbidity in patients with small-cell lung cancer: trends and prognostic impact. Clin Lung Cancer. 2015;16(4):282–291. doi:10.1016/j.cllc.2014.12.003.
   PubMed Web of Science ®Google Scholar
• Ludbrook JJS, Truong PT, MacNeil MV, Lesperance M, Webber A, Joe H, et al. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis. Int J Radiat Oncol Biol Phys. 2003;55(5):1321–1330. doi:10.1016/s0360-3016(02)04576-5.
   PubMed Web of Science ®Google Scholar
• Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR, et al. How do patient and hospital features influence outcomes in small-cell lung cancer in England? Br J Cancer. 2011;105(6):746–752. doi:10.1038/bjc.2011.310.
   PubMed Web of Science ®Google Scholar
• Lüchtenborg M, Riaz SP, Lim E, Page R, Baldwin DR, Jakobsen E, et al. Survival of patients with small cell lung cancer undergoing lung resection in England, 1998–2009. Thorax. 2014;69(3):269–273. doi:10.1136/thoraxjnl-2013-203884.
   PubMed Web of Science ®Google Scholar
• Janssen-Heijnen ML, Lemmens VE, van den Borne BE, Biesma B, Oei SB, Coebergh JWW. Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: a population-based study in the Netherlands. Crit Rev Oncol Hematol. 2007;62(2):172–178. doi:10.1016/j.critrevonc.2006.11.005.
   PubMed Web of Science ®Google Scholar
• Xiu W, Huang Y, Li Y, Yu M, Gong Y. Comorbidities and mortality risk among extensive-stage small-cell lung cancer patients in mainland China: impact of hypertension, type 2 diabetes mellitus, and chronic hepatitis B virus infection. Anticancer Drugs. 2022;33(1):80–90. doi:10.1097/CAD.0000000000001133.
   PubMed Web of Science ®Google Scholar
• Lee SY, Kim MT, Lee SH, Im SJ. Does hypertension increase mortality risk from lung cancer? A prospective cohort study on smoking, hypertension and lung cancer risk among Korean men. J Hypertens. 2002;20(4):617–622. doi:10.1097/00004872-200204000-00017.
   PubMed Web of Science ®Google Scholar
• Dima S, Chen KH, Wang KJ, Wang KM, Teng NC. Effect of comorbidity on lung cancer diagnosis timing and mortality: a nationwide population-based cohort study in Taiwan. Biomed Res Int. 2018; 2018:1252897. doi:10.1155/2018/1252897.
   PubMed Web of Science ®Google Scholar
• Yap A, Lopez-Olivo MA, Dubowitz J, Pratt G, Hiller J, Gottumukkala V, et al. Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies. Br J Anaesth. 2018;121(1):45–57. doi:10.1016/j.bja.2018.03.024.
   PubMed Web of Science ®Google Scholar
• Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer. 2009;16(4):1103–1123. doi:10.1677/ERC-09-0087.
   PubMed Web of Science ®Google Scholar
• Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systemic review and meta-analysis. Jama. 2008;300(23):2754–2764. doi:10.1001/jama.2008.824.
   PubMed Web of Science ®Google Scholar
• Islam KMM, Jiang X, Anggondowati T, Lin G, Ganti AK. Comorbidity and survival in lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2015;24(7):1079–1085. doi:10.1158/1055-9965.EPI-15-0036.
   PubMed Web of Science ®Google Scholar
• Luo J, Hendryx M, Qi L, Ho GY, Margolis KL. Pre-existing diabetes and lung cancer prognosis. Br J Cancer. 2016;115(1):76–79. doi:10.1038/bjc.2016.141.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wu F, Saito E, Lin Y, Song M, Luu HN, et al. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771 000 individuals in the Asia Cohort Consortium. Diabetologia. 2017;60(6):1022–1032. doi:10.1007/s00125-017-4229-z.
   PubMed Web of Science ®Google Scholar
• Inal A, Kaplan MA, Kucukoner M, Urakci Z, Karakus A, Nas N, et al. et al. Is diabetes mellitus a prognostic factor for survival in patients with small cell lung cancer? Asian Pac J Cancer Prev. 2012;13(4):1491–1494. doi:10.7314/apjcp.2012.13.4.1491.
   PubMedGoogle Scholar
• Kurishima K, Watanabe H, Ishikawa H, Satoh H, Hizawa N. Survival of patients with lung cancer and diabetes mellitus. Mol Clin Oncol. 2017;6(6):907–910. doi:10.3892/mco.2017.1224.
   PubMedGoogle Scholar
• Nakazawa K, Kurishima K, Tamura T, Ishikawa H, Satoh H, Hizawa N. Survival difference in NSCLC and SCLC patients with diabetes mellitus according to the first-line therapy. Med Oncol. 2013;30(1):367. doi:10.1007/s12032-012-0367-9.
   PubMed Web of Science ®Google Scholar
• Ju S, Lee HR, Kim JY, Kim HC, Lee GW, You JW, et al. Impact of coexistent chronic obstructive pulmonary disease on the survival of patients with small cell lung cancer receiving chemotherapy. Thorac Cancer. 2018;9(10):1271–1278. doi:10.1111/1759-7714.12832.
   PubMed Web of Science ®Google Scholar
• Liao KM, Hung CM, Shu CM, Lee HS, Wei YF. Impact of Chronic obstructive pulmonary disease on the mortality of patients with small cell lung cancer. Int J Chron Obstruct Pulmon Dis. 2021;16:3255–3262. doi:10.2147/COPD.S328938.
   PubMed Web of Science ®Google Scholar